Cattaneo et al, 1998), and type 1 plasminogen activation inhibitor (Freyburger et al, 1997) have been reported
Calcium upregulation by percutaneous administration of gene therapy in patients with cardiac disease (CUPID 2): a randomised, multinational, double-blind, placebo-controlled, phase 2b trial
We monitor your response carefully to ensure your comfort and safety
Without sun protection, even the best treatments may fail or pigmentation may worsen
Antioxidant Support The level of oxidative stress in the body is a huge factor determining health status
Studies have progressed from initial in vitro observations to controlled clinical trials, particularly in the dermatological field